The role of TOR signaling in aging

The Comparative Biology of Aging

Volumn , Issue , 2010, Pages 147-161

  Kaeberlein, Matt ^a   Shamieh, Lara S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autophagy; Dietary restriction; mRNA translation; mTOR; Target of rapamycin

Indexed keywords

EID: 84900042030     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-3465-6_7     Document Type: Chapter

References (95)

1. Vezina C, Kudelski A, and Sehgal SN (1975). Rapamycin (AY-22,989), a new antifungal antibiotic I Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 28: 721-726.
2. Heitman J, Movva NR, and Hall MN (1991). Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253: 905-909.
3. De Virgilio C and Loewith R (2006). The TOR signalling network from yeast to man. Int J Biochem Cell Biol 38: 1476-1481.
4. Martin DE and Hall MN (2005). The expanding TOR signaling network. Curr Opin Cell Biol 17: 158-166.
5. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, and Sabatini DM (2006). Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11: 859-871.
6. Helliwell SB, Howald I, Barbet N, and Hall MN (1998). TOR2 is part of two related signaling pathways coordinating cell growth in Saccharomyces cerevisiae. Genetics 148: 99-112.
7. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, and Su B (2006). SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127: 125-137.
8. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, and Sabatini DM (2004). Rictor, a novel binding partner of mTOR, defines a rapamycininsensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14: 1296-1302.
9. Gingras AC, Svitkin Y, Belsham GJ, Pause A, and Sonenberg N (1996). Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus. Proc Natl Acad Sci USA 93: 5578-5583.
10. Inoki K, Li Y, Xu T, and Guan KL (2003). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17: 1829-1834.
11. Inoki K, Li Y, Zhu T, Wu J, and Guan KL (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648-657.
12. Manning BD, Tee AR, Logsdon MN, Blenis J, and Cantley LC (2002). Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10: 151-162.
13. Long X, Muller F, and Avruch J (2004). TOR action in mammalian cells and in Caenorhabditis elegans. Curr Top Microbiol Immunol 279: 115-138.
14. Long X, Spycher C, Han ZS, Rose AM, Muller F, and Avruch J (2002). TOR deficiency in C elegans causes developmental arrest and intestinal atrophy by inhibition of mRNA translation. Curr Biol 12: 1448-1461.
15. Apfeld J, OConnor G, McDonagh T, DiStefano PS, and Curtis R (2004). The AMP-Activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C elegans. Genes Dev 18: 3004-3009.
16. Chen D, Pan KZ, Palter JE, and Kapahi P (2007). Longevity determined by developmental arrest genes in Caenorhabditis elegans. Aging Cell 6: 525-533.
17. Curran SP and Ruvkun G (2007). Lifespan regulation by evolutionarily conserved genes essential for viability. PLoS Genet 3: e56.
18. Curtis R, OConnor G, and DiStefano PS (2006). Aging networks in Caenorhabditis elegans: AMP-Activated protein kinase (aak-2) links multiple aging and metabolism pathways. Aging Cell 5: 119-126.
19. Fabrizio P, Pletcher SD, Minois N, Vaupel JW, and Longo VD (2004). Chronological agingindependent replicative life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae. FEBS Lett 557: 136-142.
20. Fabrizio P, Pozza F, Pletcher SD, Gendron CM, and Longo VD (2001). Regulation of longevity and stress resistance by Sch9 in yeast. Science 292: 288-290.
21. Hansen M, Chandra A, Mitic LL, Onken B, Driscoll M, and Kenyon C (2008). A Role for Autophagy in the Extension of Lifespan by Dietary Restriction in C elegans. PLoS Genet 4: e24.
22. Hansen M, Taubert S, Crawford D, Libina N, Lee SJ, and Kenyon C (2007). Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 6: 95-110.
23. Jia K, Chen D, and Riddle DL (2004). The TOR pathway interacts with the insulin signaling pathway to regulate C elegans larval development, metabolism and life span. Development 131: 3897-3906.
24. Jiang JC, Jaruga E, Repnevskaya MV, and Jazwinski SM (2000). An intervention resembling caloric restriction prolongs life span and retards aging in yeast. Faseb J 14: 2135-2137.
25. Kaeberlein M, Powers RW, 3rd, Steffen KK, Westman EA, Hu D, Dang N, Kerr EO, Kirkland KT, Fields S, and Kennedy BK (2005b). Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310: 1193-1196.
26. Kaeberlein TL, Smith ED, Tsuchiya M, Welton KL, Thomas JH, Fields S, Kennedy BK, and Kaeberlein M (2006b). Lifespan extension in Caenorhabditis elegans by complete removal of food. Aging Cell 5: 487-494.
27. Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, and Benzer S (2004). Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 14: 885-890.
28. Klass MR (1977). Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span.Mech Ageing Dev 6: 413-429.
29. Lakowski B and Hekimi S (1998). The genetics of caloric restriction in Caenorhabditis elegans. Proc Natl Acad Sci USA 95: 13091-13096.
30. Lee GD,Wilson MA, Zhu M,Wolkow CA, de Cabo R, Ingram DK, and Zou S (2006). Dietary deprivation extends lifespan in Caenorhabditis elegans. Aging Cell 5: 515-524.
31. Lin SJ, Defossez PA, and Guarente L (2000). Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128.
32. Mair W, Goymer P, Pletcher SD, and Partridge L (2003). Demography of dietary restriction and death in Drosophila. Science 301: 1731-1733.
33. Murakami CJ, Burtner CR, Kennedy BK, and Kaeberlein M (2008). A method for highthroughput quantitative analysis of yeast chronological life span. J Gerontol A Biol Sci Med Sci 63: 113-121.
34. Powers RW 3rd, Kaeberlein M, Caldwell SD, Kennedy BK, and Fields S (2006). Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev 20: 174-184.
35. Smith Jr. D.L., McClure JM, Matecic M, and Smith JS (2007). Calorie restriction extends the chronological lifespan of Saccharomyces cerevisiae independently of the Sirtuins. Aging Cell 6: 649-662.
36. Smith ED, Tsuchiya M, Fox LA, Dang N, Hu D, Kerr EO, Johnston ED, Tchao BN, Pak DN, Welton KL, et al. (2008). Quantitative evidence for conserved longevity pathways between divergent eukaryotic species. Genome Res 18: 564-570.
37. Steffan KK, MacKay VL, Kerr EO, Tsuchiya M, Hu D, Fox LA, Dang N, Johnston ED, Oakes JA, Tchao BN, et al. (2008). Yeast lifespan extension by depletion of 60S ribosomal subunits is mediated by Gcn4. Cell 133: 292-302.
38. Syntichaki P, Troulinaki K, and Tavernarakis N (2007). eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans. Nature 445: 922-926.
39. Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, and Muller F (2003). Genetics: influence of TOR kinase on lifespan in C elegans. Nature 426: 620.
40. Weindruch RH and Walford RL (1988). The Retardation of Aging and Disease by Dietary Restriction. Springfield, IL: Thomas.
41. Kaeberlein M (2006). Longevity and aging in the budding yeast. In Handbook of Models for Human Aging. (PM Conn, ed.). Boston: Elsevier Press, pp. 109-120.
42. Mortimer RK and Johnston JR (1959). Life span of individual yeast cells. Nature 183: 1751-1752.
43. Fabrizio P and Longo VD (2003). The chronological life span of Saccharomyces cerevisiae. Aging Cell 2: 73-81.
44. Kaeberlein M, Kirkland KT, Fields S, and Kennedy BK (2004). Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol 2: E296.
45. Loewith R, Jacinto E,Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, OppligerW, Jenoe P, and Hall MN (2002). Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 10: 457-468.
46. Helliwell SB, Wagner P, Kunz J, Deuter-Reinhard M, Henriquez R, and Hall MN (1994). TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol Biol Cell 5: 105-118.
47. Crespo JL, Powers T, Fowler B, and Hall MN (2002). The TOR-controlled transcription activators GLN3, RTG1, and RTG3 are regulated in response to intracellular levels of glutamine. Proc Natl Acad Sci USA 99: 6784-6789.
48. Meissner B, Boll M, Daniel H, and Baumeister R (2004). Deletion of the intestinal peptide transporter affects insulin and TOR signaling in Caenorhabditis elegans. J Biol Chem 279: 36739-36745.
49. Pan KZ, Palter JE, Rogers AN, Olsen A, Chen D, Lithgow GJ, and Kapahi P (2007). Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 6: 111-119.
50. Lin K, Dorman JB, Rodan A, and Kenyon C (1997). daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278: 1319-1322.
51. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, and Ruvkun G (1997). The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C elegans. Nature 389: 994-999.
52. Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, Schmitt I, Wullner U, Evert BO, OKane CJ, et al. (2006). Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 15: 433-442.
53. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, OKane CJ, et al. (2004). Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36: 585-595.
54. Luong N, Davies CR, Wessells RJ, Graham SM, King MT, Veech R, Bodmer R, and Oldham SM (2006). Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity. Cell Metab 4: 133-142.
55. Masoro EJ (2005). Overview of caloric restriction and ageing. Mech Ageing Dev 126: 913-922.
56. Kapahi P and Zid B (2004). TOR pathway: linking nutrient sensing to life span. Sci Aging Knowledge Environ 2004 PE34.
57. Arsham AM and Neufeld TP (2006). Thinking globally and acting locally with TOR. Curr Opin Cell Biol 18: 589-597.
58. Bhaskar PT and Hay N (2007). The two TORCs and Akt. Dev Cell 12: 487-502.
59. Kaeberlein M, Steffen KK, Hu D, Dang N, Kerr EO, Tsuchiya M, Fields S, and Kennedy BK (2006a). Comment on HST2 mediates SIR2-independent life-span extension by calorie restriction. Science 312: 1312, author reply 1312.
60. Tsuchiya M, Dang N, Kerr EO, Hu D, Steffen KK, Oakes JA, Kennedy BK, and Kaeberlein M (2006). Sirtuin-independent effects of nicotinamide on lifespan extension from calorie restriction in yeast. Aging Cell 5: 505-514.
61. Bonawitz ND, Chatenay-Lapointe M, Pan Y, and Shadel GS (2007). Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression. Cell Metab 5: 265-277.
62. Jia K and Levine B (2007). Autophagy is required for dietary restriction-mediated life span extension in C elegans. Autophagy 3: 597-599.
63. Toth ML, Sigmond T, Borsos E, Barna J, Erdelyi P, Takacs-Vellai K, Orosz L, Kovacs AL, Csikos G, Sass M, et al. (2008). Longevity pathways converge on autophagy genes to regulate life span in Caenorhabditis elegans. Autophagy 4: 330-338.
64. Klionsky DJ (2007). Autophagy: from phenomenology to molecular understanding in less than a decade. Nat RevMol Cell Biol 8: 931-937.
65. Cuervo AM and Dice JF (2000). Age-related decline in chaperone-mediated autophagy. J Biol Chem 275: 31505-31513.
66. Melendez A, Talloczy Z, Seaman M, Eskelinen EL, Hall DH, and Levine B (2003). Autophagy genes are essential for dauer development and life-span extension in C elegans. Science 301: 1387-1391.
67. Martinez-Vicente M and Cuervo AM (2007). Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 6: 352-361.
68. Ventruti A and Cuervo AM (2007). Autophagy and neurodegeneration. Curr Neurol Neurosci Rep 7: 443-451.
69. Juhasz G, Erdi B, Sass M, and Neufeld TP (2007). Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev 21: 3061-3066.
70. Morck C and Pilon M (2006). C elegans feeding defective mutants have shorter body lengths and increased autophagy. BMC Dev Biol 6: 39.
71. Takeshige K, Baba M, Tsuboi S, Noda T, and Ohsumi Y (1992). Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J Cell Biol 119: 301-311.
72. Jia K, Hart AC, and Levine B (2007). Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans. Autophagy 3: 21-25.
73. Khan LA, Yamanaka T, and Nukina N (2008). Genetic impairment of autophagy intensifies expanded polyglutamine toxicity in Caenorhabditis elegans. Biochem Biophys Res Commun 368: 729-735.
74. Yamamoto A, Cremona ML, and Rothman JE (2006). Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 172: 719-731.
75. Wei M, Fabrizio P, Hu J, Ge H, Cheng C, Li L, and Longo VD (2008). Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9. PLoS Genet 4: e13.
76. Fabrizio P, Liou LL, Moy VN, Diaspro A, SelverstoneValentine J, Gralla EB, and Longo VD (2003). SOD2 functions downstream of Sch9 to extend longevity in yeast. Genetics 163: 35-46.
77. Medvedik O, Lamming DW, Kim KD, and Sinclair DA (2007). MSN2 and MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension in Saccharomyces cerevisiae. PLoS Biol 5: e261.
78. Kaeberlein M, Hu D, Kerr EO, TsuchiyaM,Westman EA, Dang N, Fields S, and Kennedy BK (2005a). Increased Life Span due to Calorie Restriction in Respiratory-Deficient Yeast. PLoS Genet 1: e69.
79. Butow RA and Avadhani NG (2004). Mitochondrial signaling: the retrograde response. Mol Cell 14: 1-15.
80. Kirchman PA, Kim S, Lai CY, and Jazwinski SM (1999). Interorganelle signaling is a determinant of longevity in Saccharomyces cerevisiae. Genetics 152: 179-190.
81. Dilova I, Chen CY, and Powers T (2002). Mks1 in concert with TOR signaling negatively regulates RTG target gene expression in S cerevisiae. Curr Biol 12: 389-395.
82. Powers T, Dilova I, Chen CY, and Wedaman K (2004). Yeast TOR signaling: a mechanism for metabolic regulation. Curr Top Microbiol Immunol 279: 39-51.
83. Hamilton B, Dong Y, Shindo M, Liu W, Odell I, Ruvkun G, and Lee SS (2005). A systematic RNAi screen for longevity genes in C elegans. Genes Dev 19: 1544-1555.
84. Desai BN, Myers BR, and Schreiber SL (2002). FKBP12-rapamycin-Associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci USA 99: 4319-4324.
85. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, and Sabatini DM (2002). mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163-175.
86. Schieke SM, Phillips D, McCoy JP, Jr., Aponte AM, Shen RF, Balaban RS, and Finkel T (2006). The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 281: 27643-27652.
87. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, and Puigserver P (2007). mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450: 736-740.
88. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. (2006). Resveratrol improves health and survival of mice on a highcalorie diet. Nature 444: 337-342.
89. Kaeberlein M and Kennedy BK (2007). Protein translation, 2007. Aging Cell 6: 731-734.
90. Miller RA, Harrison DE, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, et al. (2007). An Aging Interventions Testing Program: study design and interim report. Aging Cell 6: 565-575.
91. Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, Dart A, and Du XJ (2006). Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 24: 1663-1670.
92. Wullschleger S, Loewith R, and Hall MN (2006). TOR signaling in growth and metabolism. Cell 124: 471-484.
93. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, et al. (2004). Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity. Nature 431: 200-205.
94. Cheng-Lai A and Frishman WH (2004). Sirolimus-eluting coronary stents: novel devices for the management of coronary artery disease. Am J Ther 11: 218-228.
95. Weil RJ (2008). Incorporating molecular tools into early-stage clinical trials. PLoS Med 5: e21.